Home Search
geovax - search results
If you're not happy with the results, please do another search
The Extraordinary Dr. Koffman, Who Beat Leukemia.
Dr. Brian Koffman is extraordinary, in many ways. He’s extraordinary in the medical sense because, after twelve years of battling blood cancer, doctors can...
Vaxart (VXRT) Gains $171 Million in Market Value After $9.2 Million Award from Project...
Vaxart Closes $10 Million Secondary on January 16th @0.65.
Vaxart Receives $9 Million Award from Barda on January 19th.
Shares trades From a Low of $0.55...
Intelligent Bio Solutions Inc. (INBS) UP 146%, Post Reverse Split.
Crazy Fun Volatility Post Reverse Split.
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results
VOLUME AT 12:00
FINISHES THE DAY...
Reverse Stock Split, Watch List.
Cheer's Mates, Let's Get This Party Started.
WATCH LIST
Quantum Pharmaceutical (QNTM) 1:65 Reverse - August 15th, 2024. Low $3.62. Subsequent High $7.90Added to Watch List...
Corbus Pharma (CRBP) Explodes Higher After Reverse Split, up 1,288%!
From a Low of $2.11 Just Shy of a Year Ago, to an Intraday High of $29.30. A Ten Bagger in Less Than a...
Zivo Bioscience (ZIVO) Screams 2,608% Higher AFTER Reverse Split!
Okay, that's it. We are officially enamored with post reverse split trading!
First, there was our client, LQR House (LQR), then Polished (POL) and...
ATCC Announces $87 Million Award for Project NextGen for Vaccines, from Barda.
ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development...
Ardelyx (ARDX), Raymond James up Price Target, Citigroup Joins the Party.
Wall Street Cozy's up to Ardelyx After New Guidance.
On January 8th, Mike Raab, President and Chief Executive Officer stated, "We consistently grew sales of...
Is David Dodd on to his Next Billion Dollar Payday for Shareholders?
Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors.
GeoVax (GOVX) Completes Patient Enrollment for Head & Neck Cancer Drug, Gedeptin.®
David...
Two That Doubled and Now Look Ready to Break Out.. and a Third That...
We are up 234% in Ardelyx (ARDX) $5.23 since adding it to Watch List a year ago and up 71% in Cardiol Therapeutics (CRDL)...